HNRNPA2B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.878600E-01
Normal-vs-Stage2
1.645200E-01
Normal-vs-Stage3
1.428400E-01
Normal-vs-Stage4
5.646000E-01
Stage1-vs-Stage2
8.957600E-01
Stage1-vs-Stage3
2.371200E-01
Stage1-vs-Stage4
5.743000E-01
Stage2-vs-Stage3
9.037600E-02
Stage2-vs-Stage4
5.806000E-01
Stage3-vs-Stage4
1.629840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.443020E-01
Normal-vs-AfricanAmerican
3.999800E-01
Normal-vs-Asian
2.325600E-01
Caucasian-vs-AfricanAmerican
7.312000E-01
Caucasian-vs-Asian
4.779400E-01
AfricanAmerican-vs-Asian
5.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.547840E-01
Normal-vs-Female
1.516370E-01
Male-vs-Female
9.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.257400E-01
Normal-vs-Age(41-60Yrs)
2.811600E-01
Normal-vs-Age(61-80Yrs)
1.131800E-01
Normal-vs-Age(81-100Yrs)
1.244200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.046400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.555600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.629800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.796600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.055980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.301600E-01
Normal-vs-Daily Drinker
1.416000E-01
Normal-vs-Weekly Drinker
2.275600E-01
Normal-vs-Occasional Drinker
3.662000E-01
Normal-vs-Social Drinker
2.599400E-01
Non Drinker-vs-Daily Drinker
7.692000E-01
Non Drinker-vs-Weekly Drinker
9.569200E-01
Non Drinker-vs-Occasional Drinker
1.217570E-01
Non Drinker-vs-Social Drinker
2.974000E-01
Daily Drinker-vs-Weekly Drinker
8.626600E-01
Daily Drinker-vs-Occasional Drinker
9.936100E-02
Daily Drinker-vs-Social Drinker
2.341600E-01
Weekly Drinker-vs-Occasional Drinker
2.092200E-01
Weekly Drinker-vs-Social Drinker
3.851600E-01
Occasional Drinker-vs-Social Drinker
6.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.017000E-01
Normal-vs-Grade 2
8.384800E-01
Normal-vs-Grade 3
7.909000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.713800E-01
Grade 1-vs-Grade 3
7.127500E-02
Grade 1-vs-Grade 4
9.017000E-01
Grade 2-vs-Grade 3
1.559420E-01
Grade 2-vs-Grade 4
8.384800E-01
Grade 3-vs-Grade 4
7.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.231900E-02
Normal-vs-NonDiabetic
1.410050E-01
Diabetic-vs-NonDiabetic
1.686780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.997970E-01
Normal-vs-NoPancreatitis
1.355250E-01
Pancreatitis-vs-NoPancreatitis
7.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.408430E-01
Normal-vs-N1
1.702820E-01
N0-vs-N1
9.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.670000E-01
Normal-vs-TP53-NonMutant
1.735630E-01
TP53-Mutant-vs-TP53-NonMutant
1.075850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
